Inhibrx Biosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INBX and other ETFs, options, and stocks.About INBX
Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function.
INBX Key Statistics
Stock Snapshot
With a market cap of 1.88B, Inhibrx Biosciences(INBX) trades at $128.12. The stock has a price-to-earnings ratio of -14.17.
On 2026-05-06, Inhibrx Biosciences(INBX) stock moved within a range of $125.53 to $133.90. With shares now at $128.12, the stock is trading +2.1% above its intraday low and -4.3% below the session's peak.
Trading activity shows a volume of 411.75K, compared to an average daily volume of 759.56K.
Over the past 52 weeks, Inhibrx Biosciences(INBX) stock has traded between a high of $155.29 and a low of $10.84.
Over the past 52 weeks, Inhibrx Biosciences(INBX) stock has traded between a high of $155.29 and a low of $10.84.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.